1 / 8

Daily Equity Report 26 AUG 2019

Bullion Premium is one of our premium services. In this service, we provide 3-5 calls in MCX include mcx commodity tips, MCX Bullions, and Mcx live tips, Mcx tips.<br>http://www.capitalstars.com/bullion-premium-mcx-tips/<br>

Download Presentation

Daily Equity Report 26 AUG 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 26 THAUGUST 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 36472.93 INDIAN EQUITY BENCHMARK - After a weak start Indian indices ended on positive note on August 23 on hopes of stimulus package from government. Finance Minister NIFTY 10741.35 Nirmala Sitharaman will hold a press briefing on Friday CLOSE PREVIOUS evening, a government spokesman said, amid expectations NIKKEI 20628.01 that the government would announce steps to revive economic growth, said Reuters. After breaking 10,700 in the 26048.72 morning the Nifty rebounded from the lows and closed 1948.30 above 10,800 level. At close, the Sensex was up 228.23 points SECTORIAL INDICES at 36,701.16, while Nifty was up 88.00 points at 10,829.40. CLOSE CHANGE (%) About 1310 shares have advanced, 1125 shares declined, CNX 100 10925.90 and 130 shares are unchanged. IndusInd Bank, ITC, ICICI S&P CNX 500 0.82 Bank, Eicher Motors and Kotak Mahindra Bnak were among major losers on the Nifty, while gainers were Zee Entertainment, Vedanta, UPL, BPCL and Yes Bank. Among CNX 200 sectors, except bank and FMCG other indices are ended BANK NIFTY higher led by the metal, auto, pharma, infra and IT. GLOBAL FACE TOP GAINERS CLOSE CHANGE (%) ! Asian Market - Asian markets finished higher today with shares in Hong Kong leading the region. The Hang Seng is up UPL 0.50% while China's Shanghai Composite is up 0.49% and Japan's Nikkei 225 is up 0.40%. YESBANK ! TOP LOSERS U.S. Market – North and South American markets finished mixed as of the most recent closing prices. The IPC gained CLOSE CHANGE (%) 0.17%, while the Bovespa led the S&P 500 lower. They fell INDUSINDBK 1.18% and 0.05% respectively. ! European markets – European markets are higher today with shares in London leading the region. The FTSE 100 is up 0.83% while France's CAC 40 is up 0.57% and Germany's DAX ICICIBANK is up 0.42%. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE STRATEGY SELL ON RISE SCRIPT CLOSE (%) 6.55 350.50 PIVOT POINTS P 10776 S3 10325 S2 10550 S1 R1 10915 R2 11001 RESISTANCE R1-10950 R2-11100 R3 11227 329.35 5.22 10690 122.65 4.87 SUPPORT S1-10700 S2-10600 536.00 4.73 MARKET MOVERS DOWNSIDE CLOSE (%) -1.78 INDUSINDBK KOTAKBANK -0.60 POWERGRID -0.47 HDFCBANK -0.42 NET BUY (CR.) NET INSTITUTION SELL (CR) FII 6248.71 TREND STRATEGY SELL ON RISE 3248.18 PIVOT POINTS P 26968 SUPPORT S2 26334 S1 26687 R2 R3 28237 NSE TOTALS 25699 27321 27602 RESISTANCE R1-27250 R2-27400 DECLINE S INDICES BANK NIFTY NIFTY 9 8 4 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS ! ! Wockhardt rises 1% on receiving GMP Compliance Certificate for Ankleshwar facility Shares of Wockhardt rose 1% in afternoon trade after the company notified exchanges that it had received the GMP Compliance Certificate for its Ankleshwar unit. The company said in a statement, "We wish to inform the Exchanges that French National Agency for Medicines and Health Products Safety has issued GMP Compliance Certificate that the Companys manufacturing Unit at Ankleshwar, Gujarat complies with the principles of Good Manufacturing Practices for active substances. This is reflected in the Eudra GMDP database." Yes Bank clarifies on report of plan to raise additional capital Yes Bank issued a clarification on reports of the bank raising additional capital via QIP. Shares of the bank were trading higher throughout today's session and are currently up 6%. The bank in the afternoon through a filing on the NSE said that although it seeks raising capital from various sources in ordinery course of business, it is not aware of the reports that emerged today regarding the additional $1.2bn capital plan to be raised via QIP. HDFC Vaidyanathan as CFO HDFC Bank's board has appointed Srinivasan Vaidyanathan as the Chief Financial Officer (CFO) of the Bank, with immediate effect. The incumbent CFO of the Bank, Sashidhar Jagdishan would continue to head the Finance function, responsibilities as in charge of the verticals of Legal & Secretarial, Communications, Infrastructure, Corporate Social Responsibility and Change Agent of the Bank. Vaidyanathan would continue to report to Jagdish. Vaidyanathan and Jagdishan would be Key Managerial Personnel of the Bank according to Companies Act, 2013 Bank appoints Srinivasan and shoulder additional Corporate ! and the Regulations. ! Glenmark Pharma gets ANDA approval for Fulvestrant Injection Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL), a generic version of Faslodex Injection, 250 mg/5 mL (50 mg/mL), of AstraZeneca Pharmaceuticals LP. According to IQVIA sales data for the 12-month period ending June 2019, the Faslodex Injection, 250 mg/5 mL (50 mg/mL) market achieved annual sales of approximately $549.9mn. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : TATAELXSI DATE : 26/08/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY TATAELXSI IN CASH ABOVE 650 TGT 665 SL 635 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Mcx Tips Financial advisory company Sharemarket company Stock Tips Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

  8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

More Related